Vena cava filter data study for specific filter type
Part of Heart & circulation, Lungs & breathing clinical trials.
This study checks outcomes and safety using real-world health data from people who received a specific type of vena cava filter. It may help improve future care by understanding how these devices perform after placement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a Celect Platinum vena cava filter placed during a procedure
- Your case involves that specific filter type (Celect Platinum)
- You have not been part of the Cook MDR-2126 study before
- You (or your legal representative) agree to have your health data collected
- You are willing to sign the informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who are getting an IVC filter placed or removed. It aims to better understand how patients do after the procedure, both in the short term and longer term.
This is a “registry” study that collects information about people who have a confirmed blood clot in a vein, lung, or a superficial vein. It may help doctors understand outcomes over time, especially what happens in the first few months after diagnosis.
This trial compares two different tools for taking out an IVC filter (a device placed in a large vein to help prevent blood clots). It’s meant to find which removal method is safer and works better for eligible adults who just had a specific filter placed.
This study tracks how well the Cleaner Vac® system works to remove blood clots from leg veins over time. It may be an option for people with new or recent deep vein thrombosis (DVT) who are getting their first treatment.
This trial tests a new device called the Recana Thrombectomy Catheter to clear blockages in the large veins of the legs or pelvis. It might help people with chronic leg swelling, pain, or open sores caused by poor blood flow out of the leg.
This trial tests a new implantable valve designed to treat severe leg swelling and skin damage caused by faulty deep veins that have stopped working properly. The valve may help prevent complications and improve symptoms after standard treatments haven't fully worked.
Hear when a new Deep Vein Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.